Perrigo Company plc
NYSE:PRGODrug Manufacturers - Specialty & Generic
-$0.20 today
- Market cap
- $2.35B
- Beta
- 0.52
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$13.10
- Dividend yield
- 11.65%
Volume 2.57M
Average 2.96M
PRGO Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Perrigo Company plcNYSE: PRGO
Total Equity · Q2 FY2026 · quarter ended Jun 2026
Total equity falls 43.7% from a year ago
Total equity stood at $2.52B at the end of Q2 FY2026, down 43.7% from a year earlier and up 0.7% from the prior quarter. Over 3 fiscal years it compounded at -15.4% a year.
Context
- Total equity amounted to 33.1% of total assets at the end of Q2 FY2026, down 11.2 pp from a year earlier.
- Total equity increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps falling in the next quarterly balance sheet after a -43.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 2.94B USD
- Year-over-year change
- -32.0%
- 4-year CAGR
- -13.1%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.94B | -32.0% |
| FY2024 | 2024-12-31 | 4.32B | -9.4% |
| FY2023 | 2023-12-31 | 4.77B | -1.5% |
| FY2022 | 2022-12-31 | 4.84B | -6.0% |
| FY2021 | 2021-12-31 | 5.15B | — |
Total Equity vs competitors
How PRGO compares with its peers on the latest reported figures
- PRGO's Jun 2026 total equity of $2.52B is the 2nd highest of the 10 companies compared; the peer median is $282.54M.
- Its year-over-year change of -43.7% is the 8th highest of 10, against a peer median of -3.1%.
- Total equity amounts to 33.1% of total assets for PRGO, versus a peer median of 41.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $2.9B | -18.4% | +2.4% | 41.1% | |
| Jun 2026 | $2.52B | -43.7% | -15.4% | 33.1% | |
| Sep 2026 | $1.37B | +18.6% | -0.2% | 50.6% | |
| Dec 2025 | $1.25B | +62.1% | +25.2% | 71.4% | |
| Jun 2026 | $1.03B | -3.1% | +6.2% | 72.2% | |
HTFLHeartflow, Inc. Common Stock | Sep 2026 | $282.54M | +11.0% | — | 79.5% |
| Sep 2026 | $168.68M | -31.2% | -1.9% | 37.8% | |
| Sep 2026 | $104.03M | -69.0% | +21.2% | 20.6% | |
| Mar 2026 | $18.26M | +129.3% | — | 2.3% | |
| Jun 2026 | -$802M | -645.6% | +13.1% | 3.2% | |
| Peer median (excluding PRGO) | $282.54M | -3.1% | +6.2% | 41.1% | |
Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.86B | 600.7M | 751.3M | 558.8M | 531.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 652.9M | 697.1M | 739.6M | 642.3M | 612.8M |
| Inventory | 1.02B | 1.15B | 1.14B | 1.08B | 1.15B |
| Other Current Assets | 16.1M | 271.8M | 201.1M | 199M | 504M |
| Total Current Assets | 3.86B | 2.72B | 2.83B | 2.48B | 2.8B |
| Property, Plant & Equipment (Net) | 1.03B | 1.14B | 1.1B | 1.09B | 1.07B |
| Goodwill | 3B | 3.49B | 3.53B | 3.32B | 2.05B |
| Intangible Assets | 2.15B | 3.29B | 2.99B | 2.43B | 2.35B |
| Long-term Investments | 0 | 0 | 0 | 0 | 25.4M |
| Tax Assets | 6.5M | 7.1M | 25.8M | 5.1M | 3.3M |
| Other Non-current Assets | 377.5M | 367.7M | 335.2M | 318.6M | 236.4M |
| Total Non-current Assets | 6.57B | 8.3B | 7.98B | 7.17B | 5.74B |
| Total Assets | 10.43B | 11.02B | 10.81B | 9.65B | 8.54B |
| Account Payables | 411.2M | 537.3M | 477.7M | 495.2M | 474.5M |
| Short-term Debt | 603.8M | 36.2M | 440.6M | 36.4M | 62.3M |
| Tax Payables | 16.5M | 14.4M | 42.1M | 17.4M | 20.8M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 49.1M | (28.4M) | 0 | 0 | 343.1M |
| Total Current Liabilities | 1.59B | 1.11B | 1.59B | 1.04B | 1.01B |
| Long-term Debt | 2.92B | 4.07B | 3.63B | 3.58B | 3.74B |
| Deferred Tax Liabilities | 239.3M | 368.2M | 262.3M | 203.2M | 168.9M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 382.8M | 433.5M | 559.8M | 499.2M | 511.3M |
| Total Non-current Liabilities | 3.69B | 5.06B | 4.45B | 4.28B | 4.59B |
| Total Liabilities | 5.27B | 6.18B | 6.04B | 5.33B | 5.6B |
| Common Stock | 7.04B | 6.94B | 6.84B | 6.73B | 6.61B |
| Retained Earnings | (1.93B) | (2.07B) | (2.08B) | (2.25B) | (3.68B) |
| Accumulated OCI | 35.5M | (27M) | 10.7M | (162.4M) | 14.1M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | (9.3M) |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 5.15B | 4.84B | 4.77B | 4.32B | 2.94B |
| Total Debt | 3.69B | 4.32B | 4.07B | 3.62B | 3.97B |
| Net Debt | 1.83B | 3.72B | 3.32B | 3.06B | 3.44B |
Perrigo Company plc
NYSE:PRGO
Intrinsic Alpha fair value
Locked
Current Price
$16.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.